Winter Storm Update: MSK is preparing for the coming storm. Read more

More Information: Minus iconIcon indicating subtraction, or that the element can be closed. Plus IconIcon indicating addition, or that the element can be opened. Arrow (down) icon.An arrow icon, usually indicating that the containing element can be opened and closed.

Emily Craig Zabor, MS

Research Biostatistician II

Office Phone




University of Minnesota

Emily’s primary collaboration is with the breast surgery service, where she works on numerous projects related to treatment and outcomes following surgery for breast cancer. In addition, Emily works on projects with the renal service and exercise physiology. Emily also collaborates internally with a number of investigators. Emily and Dr. Helena Furberg have studied the impact of smoking intensity and duration on prognosis in urologic cancers, including bladder and kidney cancer, and are now actively investigating the role of BMI and metabolic health on prognosis. Emily and Dr. Talya Salz are collaborating to build predictive models for cardiac outcomes among lymphoma survivors. Finally, Emily and Dr. Colin Begg have worked to develop statistical methods to assess etiologic heterogeneity. Together they have pursued analyses in both case-control as well as case-only settings and among both single primary and double primary cancers including melanoma, breast and kidney cancer.


Zabor, E. C., Furberg, H., Mashni, J., Lee, B., Jaimes, E. A., Russo, P. (2016). Factors Associated with Recovery of Renal Function following Radical Nephrectomy for Kidney Neoplasms. Clin J Am Soc Nephrol, 11(1), 101-107.

Zabor, E. C., Heller, G., Schwartz, L. H., Chapman, P. B. (2016). Correlating Surrogate Endpoints with Overall Survival at the Individual Patient Level in BRAFV600E-Mutated Metastatic Melanoma Patients Treated with Vemurafenib. Clin Cancer Res, 22(6), 1341-1347.

Begg, C. B., Orlow, I., Zabor, E. C., Arora, A., Sharma, A., Seshan, V. E., Bernstein, J. L. (2015). Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer. Cancer Med, 4(9), 1432-1439.

Begg, C. B., Seshan, V. E., Zabor, E. C., Furberg, H., Arora, A., Shen, R., … Hsieh, J. J. (2014). Genomic investigation of etiologic heterogeneity: methodologic challenges. BMC Med Res Methodol, 14, 138.

Begg, C. B., Zabor, E. C., Bernstein, J. L., Bernstein, L., Press, M. F., Seshan, V. E. (2013). A conceptual and methodological framework for investigating etiologic heterogeneity. Stat Med, 32(29), 5039-5052.

Zabor, E. C., Gonen, M., Chapman, P. B., Panageas, K. S. (2013). Dynamic prognostication using conditional survival estimates. Cancer, 119(20), 3589-3592.

Zabor, E. C., Li, Y., Thornton, L. M., Shuman, M. R., Bulik, C. M., Lichtenstein, P., … Furberg, H. (2013). Initial reactions to tobacco use and risk of future regular use. Nicotine Tob Res, 15(2), 509-517.

Begg, C. B., Zabor, E. C. (2012). Detecting and exploiting etiologic heterogeneity in epidemiologic studies. Am J Epidemiol, 176(6), 512-518.

My Downloads